Nov Inc (NOV) Stock by the Numbers

InvestorsObserver gives Nov Inc (NOV) a weak valuation score of 21 from its analysis. The proprietary scoring system considers the underlying health of a company by analyzing its stock price, earnings, and growth rate. NOV currently holds a better value than 21% of stocks based on these metrics. Long term investors focused on buying-and-holding should find the valuation ranking system most relevant when making investment decisions.

NOV gets a 21 Valuation Rank today. Find out what this means to you and get the rest of the rankings on NOV!

See Full NOV Report

Metrics Analysis

NOV has a trailing twelve month Price to Earnings (PE) ratio of 15.38 which places it around the histroical average of roughly 15. NOV is currently trading at a average value due to investors paying around what the stock is worth in relation to its earnings. NOV's trailing-12-month earnings per share (EPS) of 1.05 does justify its share price in the market. Trailing PE ratios do not factor in the company's projected growth rate, thus, some firms will have high PE ratios caused by high growth recruiting more investors even if the underlying company has produced low earnings so far. NOV currently has a 12-month-forward-PE-to-Growth (PEG) ratio of 0.29. The market is currently undervaluing NOV in relation to its projected growth due to the PEG ratio being below the fair market value of 1. NOV's PEG comes from its forward price to earnings ratio being divided by its growth rate. Because PEG ratios include more fundamentals of a company's overall health with additional focus on the future, they are one of the most used valuation metrics by analysts.

Summary

All together these valuation metrics paint a pretty strong picture for NOV at its current price due to a undervalued PEG ratio despite strong growth. The PE and PEG for NOV are better than the average of the market resulting in a valuation score of 21. Click Here to get the full Report on Nov Inc (NOV) stock.